Artur Bauhofer

Senior Director Medical Affairs at Biotest

Artur Bauhofer, Prof. Dr. has extensive work experience in the medical field. From 2013 to present, they served as the Senior Director of Medical Affairs at Biotest AG, where they established a new Medical Affairs Department and coordinated external clinical research activities. Artur also led the process of selecting investigator-initiated trials (IITs) and provided scientific guidance for them. Prior to their role at Biotest AG, they held the position of Senior Scientific Advisor at the same company from 2013 to 2015, taking the lead in planning and coordinating international non-interventional studies and post-approval safety studies.

Before joining Biotest AG, Bauhofer worked as a Global Clinical Scientist at CSL Behring from 2009 to 2012 and as a Clinical Manager at Meda Pharma from 2005 to 2009. Artur'searlier experience includes serving as the Head of the Working Group Sepsis and Cytokines at Philipps-Universität Marburg from 1994 to 2005. In this role, they were responsible for various tasks, including leading a laboratory, conducting experiments in cell biology and animal research, coordinating clinical trials, and collaborating with other medical departments.

Overall, Artur Bauhofer, Prof. Dr. has a strong background in medical affairs, clinical research coordination, and leadership in the healthcare industry.

Artur Bauhofer, Prof. Dr. received their Habilitation in Chirurgische Forschung from The Philipps University of Marburg, where they studied from 1994 to 2005. Prior to that, they obtained their Promotion in Dr. rer. nat. from the University of Konstanz, where they studied from 1985 to 1994. In 2008, they obtained an additional certification as an APL Professor from Philipps University of Marburg.

Location

Dreieich, Germany

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Biotest

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.


Industries

Headquarters

Dreieich, Germany

Employees

1,001-5,000

Links